Squarepoint Capital

Type

Hedge fund

Status

Active

Location

New York, United States

Total investments

13

Average round size

132M

Portfolio companies

10

Rounds per year

1.30

Lead investments

1

Follow on index

0.23

Areas of investment
BiotechnologyHealth CareHealth DiagnosticsWellnessMobile AppsMedical DeviceMedicalPersonal HealthService IndustryElder Care

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
13
Lead investments
1
Rounds per year
1.30
Follow on index
0.23
Investments by industry
  • Health Care (8)
  • Medical Device (4)
  • Biotechnology (4)
  • Personal Health (4)
  • Health Diagnostics (4)
  • Show 30 more
Investments by region
  • United States (9)
  • United Kingdom (2)
  • Germany (2)
Peak activity year
2022
Number of Unicorns
3
Number of Decacorns
3
Number of Minotaurs
2

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
12
Avg. valuation at time of investment
812M
Group Appearance index
0.92
Strategy success index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Cera 04 Aug 2022 Artificial Intelligence, Health Care, Health Diagnostics, Wellness, Mobile Apps, Personal Health, Service Industry, Elder Care Late Stage Venture 178M England, London, United Kingdom
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.